Can Removing "Zombie Cells" Slow Aging? Human Clinical Trials Are Starting to Deliver Answers
Senolytics — drugs that selectively eliminate senescent cells — have moved from mouse experiments to human clinical trials across kidney disease, Alzheimer's, and frailty. Here is an honest account…
Read the full articleYou might also wanna read
Senolytics: How Supplements Targeting Cellular Aging Could Reduce Chronic Inflammation
Aging is no longer regarded as this fundamentally mysterious thing that will always be beyond our control. We’re beginning to come up with t
drfranklipman.com·25d ago
Profiling the molecular and physiological effects of senolytic treatment on aged mice identifies immune, fibrotic and metabolic remodeling
Profiling the molecular and physiological effects of senolytic treatment on aged mice identifies immune, fibrotic and metabolic remodeling
Senolytic Treatment with Dasatinib and Quercetin Rejuvenates the Aging Kidney in Mice
There is a large body of evidence in animal studies to show that treatment with dasatinib and quercetin clears a fraction of the lingering s
Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study
Aging is a primary risk factor for disease progression in multiple sclerosis (MS). Because of this, treatments that can reduce the consequen
pnas.org·1mo ago
Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespan
Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespan
Tweaking a Macrophage Receptor Staves Off Aging in Mice
Improving macrophage-mediated senescent neutrophil clearance in mice prevented age-related decline, offering potential targets for antiaging
Comments
Sign in to join the conversation.
No comments yet. Be the first.